Press Releases Amgen Inc. Sao Paulo

Equities

AMGN34

BRAMGNBDR004

Market Closed - Sao Paulo Other stock markets 07:55:03 13/06/2024 pm IST			5-day change	1st Jan Change
57.22 ^BRL	-1.87%		-1.31%	+14.55%

14/06	Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto	DJ
14/06	Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Amgen : Continues to Propel BiTE® Technology Innovation	15/06	PU
FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE	15/06	PR
AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024	12/06	PR
Amgen : Leaders Hail Southern California’s Emergence as Biotech Innovation Hub	11/06	PU
Updates On Aflibercept Biosimilar Approvals And BPCIA Litigation	11/06	AQ
FDA Approves Amgen's BKEMV, The First Eculizumab Biosimilar	11/06	AQ
Amgen Files BPCIA Complaint Against Celltrion Regarding Denosumab	10/06	AQ
AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE	06/06	AQ
AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE	06/06	PR
AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)	05/06	PR
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE	04/06	PR
Amgen : 2024 Annual Meeting of Stockholders Presentation	01/06	PU
Supreme Court Holds Invalid Cholesterol Drug Patent That Covered Millions Of Undisclosed Antibodies	27/05	AQ
Amgen : An Underrecognized Risk Factor for Heart Disease	23/05	PU
Improving treatment responses to solid tumours with trispecific TCEs	23/05	AQ
Amgen : From the Office to the Lab, Amgen Uses AI Tools to Unlock Innovation	22/05	PU
Amgen : Actress and Producer Gina Torres Urges Hispanic Americans to Prioritize Cholesterol Care	21/05	PU
Amgen : At Milken Global Conference, Bradway Calls for Protecting U.S. Policy Ecosystem That Fosters Innovation	21/05	PU
Driving Long-Term Growth: IMDELLTRA™ Approval and Information Update Presentation	21/05	PU
Astrazeneca - New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease	20/05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Amgen Inc. Sao Paulo

Equities

AMGN34

BRAMGNBDR004

Press Releases

Filters